FdaApplication
ANDA 204724
Identifiers
- fda_app_no: ANDA204724
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2019-02-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEVELAMER HYDROCHLORIDE | SEVELAMER HYDROCHLORIDE | 800MG | TABLET;ORAL |
| SEVELAMER HYDROCHLORIDE | SEVELAMER HYDROCHLORIDE | 400MG | TABLET;ORAL |
2 products